Absence of transcriptomic signature of response to chemotherapy in metastatic colorectal carcinoma patients

Author： Laroche-Clary Audrey Kauffmann Audrey Smith Denis Laurand-Quancard Armelle Evrard Serge Brunet René Le Morvan Valérie Robert Jacques

Publisher： Future Medicine

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.13, Iss.4, 2012-03, pp. : 497-504

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Chemotherapy for Metastatic Colorectal Cancer

By Rosales Joseph Leong Lucille A.

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 3, Iss. 4, 2005-07 ,pp. : 525-529

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Bevacizumab plus FOLFIRI-3 in chemotherapy-refractory patients with metastatic colorectal cancer in the era of biotherapies

By Ghiringhelli François

Investigational New Drugs, Vol. 30, Iss. 2, 2012-04 ,pp. : 758-764

Springer Publishing Company

Access to resources Recommend Favorite

Patient beliefs that chemotherapy may be curative and care received at the end of life among patients with metastatic lung and colorectal cancer

By Mack Jennifer W. Walling Anne Dy Sydney Antonio Anna Liza M. Adams John Keating Nancy L. Tisnado Diana

Cancer, Vol. 121, Iss. 11, 2015-06 ,pp. : 1891-1897

Blackwell Publishing

Access to resources Recommend Favorite

Oral chemotherapy saves money in metastatic colorectal cancer

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 511, 2006-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

A phase II study of chloroquinoxaline sulfonamide (CQS) in patients with metastatic colorectal carcinoma (MCRC)

By Bekaii-Saab Tanios Mortazavi Amir Hicks Lee Zalupski Mark Pelley Robert Chan Kenneth Kraut Eric

Investigational New Drugs, Vol. 24, Iss. 4, 2006-07 ,pp. : 343-346

Springer Publishing Company

Access to resources Recommend Favorite